880 Participants Needed

Community Health Worker Program for Colorectal Cancer and Cardiovascular Disease

(CHURCH Trial)

Recruiting at 1 trial location
LM
OA
LM
Overseen ByLisa Matthews, EdD, MPH
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Columbia University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores a new community-based program to prevent colorectal cancer (CRC) and reduce heart disease risks. It includes two main components: SBIRT (Screening, Brief Intervention, and Referral to Treatment) for early CRC screening and treatment, and a lifestyle program called "Alive!" that promotes healthier living to lower heart disease risks linked to CRC. Participants will either receive usual referral information or participate in the SBIRT program and the "Alive!" lifestyle guide. Ideal candidates are English-speaking individuals aged 45 and older who haven't had a recent CRC screening.

As an unphased trial, this study provides a unique opportunity to contribute to innovative prevention strategies for CRC and heart disease.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It focuses on lifestyle changes and community health worker support.

What prior data suggests that this program is safe for participants?

Research has shown that the SBIRT approach used in this trial is generally safe. SBIRT stands for Screening, Brief Intervention, and Referral to Treatment. Initially developed for individuals at risk of mental health issues, this method has been tested and is considered safe and effective for promoting behavior change. It employs motivational interviewing to encourage positive changes, which participants have found manageable.

The Alive! program, included in this trial, is an online lifestyle coaching tool designed to enhance physical activity and eating habits. This program poses low risk as it provides guidance and support for healthier living.

Both components of the trial aim to improve health through education and motivation. Studies reviewed have not identified any specific negative effects or safety concerns.12345

Why are researchers excited about this trial?

Researchers are excited about the SBIRT approach for addressing colorectal cancer and cardiovascular disease because it's a novel way of combining behavioral health strategies with lifestyle coaching. Unlike traditional approaches that might focus solely on medical treatments or surgery, SBIRT integrates Screening, Brief Intervention, and Referral to Treatment with Motivational Interviewing to boost lifestyle changes. Additionally, the culturally-adapted Alive! Program offers a personalized, web-based platform to coach individuals on physical activity, eating habits, and weight control, making the intervention more accessible and tailored to individual needs. This dual focus on behavior change and lifestyle improvements sets it apart from standard care options, potentially leading to more sustainable health outcomes.

What evidence suggests that this trial's treatments could be effective for colorectal cancer and cardiovascular disease?

Research has shown that SBIRT (Screening, Brief Intervention, and Referral to Treatment) increases the number of people screened for health issues like colorectal cancer. It employs motivational interviewing, a method that encourages health changes by addressing mixed feelings. Studies have found that SBIRT effectively connects people to necessary treatments. In this trial, participants in the SBIRT arm will also receive a culturally-adapted online program called Alive!, which helps improve lifestyle habits like diet and exercise. Initial evidence suggests that combining these methods can lower risk factors for both colorectal cancer and heart disease. Meanwhile, participants in the Referral as Usual (RAU) arm will receive standard educational materials and contact information for screening services.12367

Who Is on the Research Team?

OA

Olajide A. Williams, MD, MS

Principal Investigator

Columbia University

Are You a Good Fit for This Trial?

This trial is for English-speaking Black individuals aged 45 and older who are not current with colorectal cancer (CRC) screenings, have a working telephone, and can provide informed consent. There are no specific exclusion criteria listed.

Inclusion Criteria

Can provide informed consent
I have a working telephone.
Not up-to-date with CRC
See 3 more

Exclusion Criteria

I am younger than 45 years old.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intervention

Participants receive the SBIRT intervention, including Screening, Brief Intervention, and Referral to Treatment, along with the culturally-adapted Alive! program for lifestyle coaching.

6 months
Regular virtual interactions through the Alive! program

Follow-up

Participants are monitored for CRC screening uptake and changes in dietary and cardiovascular health scores.

6 months
Follow-up assessments at 6 months and 1 year post-screening

What Are the Treatments Tested in This Trial?

Interventions

  • Referral as Usual (RAU)
  • SBIRT
Trial Overview The study tests a community-based CRC prevention model focusing on reducing both CRC and cardiovascular disease risks. It compares the effectiveness of CHW-led SBIRT (Screening, Brief Intervention, Referral to Treatment) versus usual referral methods on CRC screening uptake and evaluates a web-based program 'Alive!' targeting CVD risk factors.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: Screening, Brief Intervention, and Referral to Treatment (SBIRT)Experimental Treatment1 Intervention
Group II: Referral as Usual (RAU)Active Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Columbia University

Lead Sponsor

Trials
1,529
Recruited
2,832,000+

National Institute on Minority Health and Health Disparities (NIMHD)

Collaborator

Trials
473
Recruited
1,374,000+

Published Research Related to This Trial

A community health worker (CHW)-delivered cancer education program significantly improved knowledge about colorectal cancer screening among 637 participants in a medically underserved area of Appalachian Kentucky, with scores rising from 4.27 to 4.57 after the intervention (p < .001).
The program also led to an increase in participants asking their healthcare providers about colorectal cancer screening, from 27.6% at baseline to 34.1% at follow-up (p = .013), demonstrating the effectiveness of CHWs in promoting health awareness and engagement.
Effectiveness of community health workers in providing outreach and education for colorectal cancer screening in Appalachian Kentucky.Feltner, FJ., Ely, GE., Whitler, ET., et al.[2022]
Engaging community health workers in cancer screening interventions significantly increased screening rates for breast (11.5 percentage points), cervical (12.8 percentage points), and colorectal cancers (10.5 percentage points) across 76 studies, regardless of participants' race, income, or insurance status.
These interventions are effective whether community health workers operate independently or as part of a team, highlighting their role in improving health equity and access to cancer screening in underserved communities.
Community Health Workers to Increase Cancer Screening: 3 Community Guide Systematic Reviews.Okasako-Schmucker, DL., Peng, Y., Cobb, J., et al.[2023]
Training lay health workers (LHWs) about colorectal cancer (CRC) and screening significantly increased knowledge among participants, with 73 out of 81 recruited individuals having not previously received screening.
The outreach led to a substantial increase in CRC screening rates, with 55.7% of participants completing a fecal occult blood test after the educational sessions, demonstrating the effectiveness of LHWs in promoting health education and screening.
A pilot study of lay health worker outreach and colorectal cancer screening among Chinese Americans.Nguyen, TT., Love, MB., Liang, C., et al.[2022]

Citations

Community Health Workers United to Reduce Colorectal ...The study intervention has two components: Screening, Brief Intervention, and Referral to Treatment (SBIRT) to address CRC screening and a web-based lifestyle ...
2.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/38659874/
Community Health workers United to Reduce Colorectal ...Community Health workers United to Reduce Colorectal cancer and cardiovascular disease among people at Higher risk (CHURCH): study protocol for ...
Community Health workers United to Reduce Colorectal ...Screening, brief intervention, and referral to treatment. Multiple studies have found SBIRT to be effective in increasing referral rates for mental health- ...
Community Health Worker Program for Colorectal Cancer ...It compares the effectiveness of CHW-led SBIRT (Screening, Brief Intervention, Referral to Treatment) versus usual referral methods on CRC screening uptake and ...
Community Health Workers United to Reduce Colorectal ...ABSTRACT: The overall goal of this study is to develop a comprehensive, culturally tailored community-based colorectal cancer (CRC) prevention model with a ...
Technical Assistance Publication Series (Tap 33)A primary aspect of screening, brief intervention, brief treatment, and referral to treatment (SBIRT) is the integration and coordination of screening and ...
Improving screening, brief intervention and referral to ...SBIRT is a metric that uses several different ways to calculate performance outcomes, and the completeness and quality of the SBIRT data ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security